000 01292 a2200337 4500
005 20250512234008.0
264 0 _c19830415
008 198304s 0 0 eng d
022 _a0306-5251
024 7 _a10.1111/j.1365-2125.1983.tb05875.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPinder, R M
245 0 0 _aThe potential therapeutic role of the enantiomers and metabolites of mianserin.
_h[electronic resource]
260 _bBritish journal of clinical pharmacology
_c1983
300 _a269S-276S p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 0 4 _aAnimals
650 0 4 _aBehavior, Animal
_xdrug effects
650 0 4 _aBinding, Competitive
650 0 4 _aDibenzazepines
_xpharmacology
650 0 4 _aHumans
650 0 4 _aMianserin
_xmetabolism
650 0 4 _aMuscle Contraction
_xdrug effects
650 0 4 _aReceptors, Histamine
_xdrug effects
650 0 4 _aReceptors, Histamine H1
_xdrug effects
650 0 4 _aReceptors, Serotonin
_xdrug effects
650 0 4 _aStereoisomerism
700 1 _aVan Delft, A M
773 0 _tBritish journal of clinical pharmacology
_gvol. 15 Suppl 2
_gp. 269S-276S
856 4 0 _uhttps://doi.org/10.1111/j.1365-2125.1983.tb05875.x
_zAvailable from publisher's website
999 _c6824294
_d6824294